IS PSA DENSITY OR PSA (OR NEITHER) USEFUL TO PREDICT BIOPSY RECLASSIFICATION IN ACTIVE SURVEILLANCE PATIENTS?

被引：0
|
作者：
Fazeli, Roghayeh
Mamawala, Mufaddal
Landis, Patricia
Wolf, Sacha
Carter, H. Ballentine
Trock, Bruce J.
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2532
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP15-08
引用
收藏
页码：E154 / E155
页数：2
相关论文
共 50 条
  • [21] HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
    Webb, Lindsey T.
    Diaz, Gabriela M.
    Rahman, Syed N.
    Khajir, Ghazal
    Sprenkle, Preston C.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E504 - E505
  • [22] Association of PI-RADS categories and PSA density with active surveillance progression in patients with prostate cancer
    Wang, Alex Z.
    O'Connor, Luke P.
    Yerram, Nitin
    Zeng, Johnathan
    Mehralivand, Sherif
    Harmon, Stephanie
    Gurram, Sandeep
    Chalfin, Heather
    Telfer, Siobhan
    Lebastchi, Amir H.
    Ahdoot, Michael
    Gomella, Patrick H.
    Merino, Maria J.
    Turkbey, Baris
    Wood, Bradford J.
    Choyke, Peter L.
    Pinto, Peter A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] RELATIONSHIP BETWEEN INITIAL PSA DENSITY WITH FUTURE PSA KINETICS AND REPEAT BIOPSIES IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE.
    Kotb, Ahmed
    Tanguay, Simon
    Luz, Murilo
    Kassouf, Wassim
    Aprikian, Armen
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E673 - E674
  • [24] The role of mpMRI and PSA density in patients with an initial negative prostatic biopsy
    Kotb, Ahmed Fouad
    Spaner, Shelley
    Crump, Trafford
    Hyndman, Matthew Eric
    [J]. WORLD JOURNAL OF UROLOGY, 2018, 36 (12) : 2021 - 2025
  • [25] The role of mpMRI and PSA density in patients with an initial negative prostatic biopsy
    Ahmed Fouad Kotb
    Shelley Spaner
    Trafford Crump
    Matthew Eric Hyndman
    [J]. World Journal of Urology, 2018, 36 : 2021 - 2025
  • [26] The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?
    Roscigno, Marco
    Stabile, Armando
    Lughezzani, Giovanni
    Pepe, Pietro
    Galosi, Andrea Benedetto
    Naselli, Angelo
    Naspro, Richard
    Nicolai, Maria
    La Croce, Giovanni
    Aljoulani, Muhannad
    Perugini, Giovanna
    Guazzoni, Giorgio
    Montorsi, Francesco
    Balzarini, Luca
    Sironi, Sandro
    Da Pozzo, Luigi Filippo
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : E698 - E704
  • [27] ROLE OF MPMRI PSA DENSITY AND PIRADS SCORE IN PREDICTING UPSTAGING IN MEN ON ACTIVE SURVEILLANCE
    Van Kuiken, Michelle
    Blackwell, Robert H.
    Bisanz, Bryan
    Yacoub, Joseph
    Goldberg, Ari
    Shea, Steven
    Quek, Marcus
    Gupta, Gopal N.
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E1054 - E1054
  • [28] PSA Kinetics: No Substitute for Annual Biopsy in Prostate Cancer Surveillance?
    Schmidt, Charlie
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (20) : 1533 - 1535
  • [29] OUTCOMES FOLLOWING ACTIVE SURVEILLANCE IN PROSTATE CANCER PATIENTS WITH A PSA > 10
    Toren, Paul
    Wong, Lih-Ming
    Timilshina, Narhari
    Finelli, Antonio
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E91 - E92
  • [30] Can PSA doubling time exactly predict the candidates for active surveillance in patients with low-risk prostate cancer?
    Maruyama, Satoru
    Shinohara, Nobuo
    Abe, Takashige
    Sazawa, Ataru
    Nonomura, Katsuya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
12345